Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous systemAbdiwahab A. Musse, Fabrizio G. Mastronardi, Zhen Li et al.|Disease Models & Mechanisms|2008Cited by 131
Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activitiesD. D. Wood, Mario A. Moscarello, Cameron Ackerley et al.|Laboratory Investigation|2008Cited by 127
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosisMario A. Moscarello, D. D. Wood, Fabrizio G. Mastronardi et al.|Disease Models & Mechanisms|2012Cited by 100
Demyelination in a transgenic mouse: A model for multiple sclerosisFabrizio G. Mastronardi, M.A. Moscarello, Cameron Ackerley et al.|Journal of Neuroscience Research|1993Cited by 85
Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis.Fabrizio G. Mastronardi, M.A. Moscarello, Baldwin Mak et al.|Journal of Clinical Investigation|1996Cited by 42